CW May 2004Issue Number 5 May 2004 ISSN 10593802 Anticoagulant may Improve Late-stage Cancer SurvivalThough the small molecular weight anticoagulant Fragmin (dalteperin), did not significantly improve the survival rate of advanced cancer patients, this drug did improve the survival in a subgroup of patients with a better prognosis.
Go to Previous Page Go to Next Page Source & Additional Reading Journal of Clinical Oncology, May 15, 2004. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW May 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |